Unresectable Pleural Mesothelioma clinical trials

Explore recruiting unresectable pleural mesothelioma clinical trials.

Recruiting unresectable pleural mesothelioma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Unresectable Pleural Mesothelioma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase III, Randomized, Open-Label, Multicenter, Global Study of Volrustomig (MEDI5752) in Combination with Carboplatin plus Pemetrexed Versus Platinum plus Pemetrexed or Nivolumab plus Ipilimumab in Participants with Unresectable Pleural Mesothelioma (eVOLVE-Meso)

Norway, France, Germany, Belgium, Spain, Poland +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase II, Multi-Center, Master Protocol to Evaluate the Efficacy and Safety of Volrustomig as Monotherapy or in Combination with Anti-cancer Agents in Participants with Advanced/Metastatic Solid Tumors (eVOLVE-02)

Italy, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Unresectable Pleural Mesothelioma trials by city

Unresectable Pleural Mesothelioma in Toronto Unresectable Pleural Mesothelioma in Vancouver Unresectable Pleural Mesothelioma in Montreal Unresectable Pleural Mesothelioma in Calgary Unresectable Pleural Mesothelioma in Edmonton Unresectable Pleural Mesothelioma in Ottawa Unresectable Pleural Mesothelioma in Winnipeg Unresectable Pleural Mesothelioma in Quebec City Unresectable Pleural Mesothelioma in Hamilton Unresectable Pleural Mesothelioma in Kitchener Unresectable Pleural Mesothelioma in London Unresectable Pleural Mesothelioma in Halifax Unresectable Pleural Mesothelioma in New York Unresectable Pleural Mesothelioma in Los Angeles Unresectable Pleural Mesothelioma in Chicago Unresectable Pleural Mesothelioma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease